Clopidogrel use and smoking cessation result in lower coated-platelet levels after stroke

References

• Dale GL, Friese P, Batar P, Hamilton SF, Reed GL, Jackson KW, Clemetson KJ, Alberio L. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 2002;415:175–179. doi:10.1038/415175a
   PubMed Web of Science ®Google Scholar
• Dale GL. Coated-platelets: an emerging component of the procoagulant response. J Thromb Haemostasis 2005;3:2185–2192. doi:10.1111/j.1538-7836.2005.01274.x
   PubMed Web of Science ®Google Scholar
• Szasz R, Dale GL. COAT-platelets. Current Opinion Hematol 2003;10:351–355. doi:10.1097/00062752-200309000-00005
   PubMed Web of Science ®Google Scholar
• Dale GL, Remenyi G, Friese P. Quantitation of microparticles released from coated-platelets. J Thromb Haemostasis 2005;3:2081–2088. doi:10.1111/j.1538-7836.2005.01528.x
   PubMed Web of Science ®Google Scholar
• Remenyi G, Szasz R, Friese P, Dale GL. Role of mitochondrial permeability transition pore in coated-platelet formation. Arterioscler Thromb Vasc Biol 2005;25:467–471. doi:10.1161/01.ATV.0000152726.49229.bf
   PubMed Web of Science ®Google Scholar
• Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL. Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen and convulxin. Blood 2000;95:1694–1702.
   PubMed Web of Science ®Google Scholar
• Agbani EO, Poole AW. Procoagulant platelets: generation, function, and therapeutic targeting in thrombosis. Blood 2017;130:2171–2179. doi:10.1182/blood-2017-05-787259
   PubMed Web of Science ®Google Scholar
• Prodan CI, Joseph PM, Vincent AS, Dale GL. Coated-platelets in ischemic stroke: differences between lacunar and cortical stroke. J Thromb Haemostasis 2008;6:609–614. doi:10.1111/j.1538-7836.2008.02890.x
   PubMed Web of Science ®Google Scholar
• Prodan CI, Vincent AS, Dale GL. Coated-platelet levels are elevated in patients with transient ischemic attack. Transl Res 2011;158:71–75. doi:10.1016/j.trsl.2011.02.010
   PubMed Web of Science ®Google Scholar
• Prodan CI, Stoner JA, Cowan LD, Dale GL. Higher coated-platelet levels are associated with stroke recurrence following nonlacunar brain infarction. J Cereb Blood Flow Metab 2013;33:287–292. doi:10.1038/jcbfm.2012.168
   PubMed Web of Science ®Google Scholar
• Kirkpatrick AC, Stoner JA, Dale GL, Prodan CI. Elevated coated-platelets in symptomatic large-artery stenosis patients are associated with early stroke recurrence. Platelets 2014;25:93–96. doi:10.3109/09537104.2013.775570
   PubMed Web of Science ®Google Scholar
• Kirkpatrick AC, Tafur AJ, Vincent AS, Dale GL, Prodan CI. Coated-platelets improve prediction of stroke and TIA in asymptomatic internal carotid artery stenosis. Stroke 2014;45:2995–3001. doi:10.1161/STROKEAHA.114.006492
   PubMed Web of Science ®Google Scholar
• Kirkpatrick AC, Vincent AS, Dale GL, Prodan CI. Coated-platelets predict stroke at 30 days following TIA. Neurology 2017;89:125–128. doi:10.1212/WNL.0000000000004090
   PubMed Web of Science ®Google Scholar
• Prodan CI, Vincent AS, Padmanabhan R, Dale GL. Coated-platelet levels are low in patients with spontaneous intracerebral hemorrhage. Stroke 2009;40:2578–2580. doi:10.1161/STROKEAHA.109.549014
   PubMed Web of Science ®Google Scholar
• Prodan CI, Vincent AS, Dale GL. Coated platelet levels correlate with bleed volume in patients with spontaneous intracerebral hemorrhage. Stroke 2010;41:1301–1303. doi:10.1161/STROKEAHA.110.581447
   PubMed Web of Science ®Google Scholar
• Prodan CI, Stoner JA, Dale GL. Lower coated-platelet levels are associated with increased mortality after spontaneous intracerebral hemorrhage. Stroke 2015;46:1819–1825. doi:10.1161/STROKEAHA.115.009068
   PubMed Web of Science ®Google Scholar
• Prodan CI, Joseph PM, Vincent AS, Dale GL. Coated-platelet levels are influenced by smoking, aspirin and selective serotonin reuptake inhibitors. J Thromb Haemostasis 2007;5:2149–2151. doi:10.1111/j.1538-7836.2007.02691.x
   PubMed Web of Science ®Google Scholar
• Norgard NB, Saya S, Hann CL, Hennebry TA, Schechter E, Dale GL. Clopidogrel attenuates coated-platelet production in patients undergoing elective coronary catheterization. J Cardiovasc Pharmacol 2008;52:536–539. doi:10.1097/FJC.0b013e3181907390
   PubMed Web of Science ®Google Scholar
• Adams HP Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 1993;24:35–41.
   PubMed Web of Science ®Google Scholar
• Jauch EC, Saver JL, Adams HP Jr., Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr., Qureshi AI, Rosenfield K, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke 2013;44:870–947. doi:10.1161/STR.0b013e318284056a
   PubMed Web of Science ®Google Scholar
• Charania R, Smith J, Vesely SK, Dale GL, Holter J. Quantitation of coated platelet potential during collection, storage, and transfusion of apheresis platelets. Transfusion 2011;51:2690–2694. doi:10.1111/j.1537-2995.2011.03179.x
   PubMed Web of Science ®Google Scholar
• Valaydon ZS, Lee P, Dale GL, Januszewski AS, Rowley KG, Nandurkar H, Karschimkus C, Best JD, Lyons TJ, Jenkins AJ. Increased coated-platelet levels in chronic haemodialysis patients. Nephrology 2009;14:148–154. doi:10.1111/j.1440-1797.2008.01026.x
   PubMed Web of Science ®Google Scholar
• Prodan CI, Szasz R, Vincent AS, Ross ED, Dale GL. Coated-platelets retain amyloid precursor protein on their surface. Platelets 2006;17:56–60. doi:10.1080/09537100500181913
   PubMed Web of Science ®Google Scholar
• Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke 2014;45:2160–2236. doi:10.1161/STR.0000000000000024
   PubMed Web of Science ®Google Scholar
• Prodan CI, Stoner JA, Cowan LD, Dale GL. Lower coated-platelet levels are associated with early hemorrhagic transformation in patients with non-lacunar brain infarction. J Thromb Haemostasis 2010;8:1185–1190. doi:10.1111/j.1538-7836.2010.03851.x
   PubMed Web of Science ®Google Scholar
• Hintze J. PASS 2014. Kaysville, UT: NCSS, LLC.; 2014. [Computer Program].
   Google Scholar
• Norgard NB, Hann CL, Dale GL. Cangrelor attenuates coated-platelet formation. Clin Appl Thromb Hemost 2009;15:177–182. doi:10.1177/1076029608321437
   PubMed Web of Science ®Google Scholar
• Messner B, Bernhard D. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Atvb 2014;34:509–515. doi:10.1161/ATVBAHA.113.300156
   Google Scholar
• Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 2005;26:1765–1773. doi:10.1093/eurheartj/ehi183
   PubMed Web of Science ®Google Scholar
• Barbieri SS, Zacchi E, Amadio P, Gianellini S, Mussoni L, Weksler BB, Tremoli E. Cytokines present in smokers‘ serum interact with smoke components to enhance endothelial dysfunction. Cardiovasc Res 2011;90:475–483. doi:10.1093/cvr/cvr032
   PubMed Web of Science ®Google Scholar
• Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009;119:3028–3035. doi:10.1161/CIRCULATIONAHA.108.768986
   PubMed Web of Science ®Google Scholar
• Jackevicius CA, Li P, Tu JV. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation 2008;117:1028–1036. doi:10.1161/CIRCULATIONAHA.107.706820
   PubMed Web of Science ®Google Scholar
• Colucci G, Stutz M, Rochat S, Conte T, Pavicic M, Reusser M, Giabbani E, Huynh A, Thurlemann C, Keller P, et al. The effect of desmopressin on platelet function: a selective enhancement of procoagulant COAT platelets in patients with primary platelet function defects. Blood 2014;123:1905–1916. doi:10.1182/blood-2013-04-497123
   PubMed Web of Science ®Google Scholar
• Mezei G, Debreceni IB, Kerenyi A, Remenyi G, Szasz R, Illes A, Kappelmayer J, Batar P. Dasatinib inhibits coated-platelet generation in patients with chronic myeloid leukemia. Platelets 2018:1–8. doi:10.1080/09537104.2018.1501470
   PubMed Web of Science ®Google Scholar